Group 1 - Tongyuan Investment recently conducted research on two listed companies, Mindray Medical and Dia Shares [1] - Mindray Medical launched the world's first clinically implemented critical care large model, "Qiyuan Critical Care Model," and established an animal medical subsidiary [1] - In the field of medical imaging, Mindray's "Ruiying Cloud++" has partnered with DeepSeek to officially release the "Ruiying·AI+" solution [1] Group 2 - Dia Shares reported a revenue of 786 million yuan for the first half of 2025, a year-on-year increase of 0.97%, and a net profit of 76 million yuan, a year-on-year increase of 131.61% [1] - The number of upgraded Hongjin theme stores increased to 76, with average sales growth of approximately 36% post-renovation [1] - Sales in first and second-tier cities grew over 40% year-on-year, while same-store sales in third to fifth-tier cities increased nearly 20% [1] - Dia Shares launched its first equity incentive plan, set to be implemented annually over four years [1] - The company plans to open 1-2 new stores in the US market, focusing on New York, Los Angeles, and San Francisco [1]